Canadian Thyroid Patients’ Federal Petition

View & Sign our petition Between August 27 and December 25, 2018, we are collecting e-signatures on the Government of Canada's official website for petitions. Our petition is called "E-1819 (Hypothyroidism)" and is available at this link: https://petitions.ourcommons.ca/en/Petition/Details?Petition=e-1819  The petition system requires a valid email address for verification and will not include your signature until …

Continue reading Canadian Thyroid Patients’ Federal Petition

REVIEW: 2018 study of hormone status on L-T4 monotherapy

Another great study by McAninch and colleagues, from Antonio Bianco's lab, has been published in a leading endocrinology journal, The Journal of Clinical Endocrinology & Metabolism. The study was announced and summarized in this press release titled "Standard Hypothyroidism Treatment Falling Short." Let's hope the endocrinology community will listen and think twice about whether its …

Continue reading REVIEW: 2018 study of hormone status on L-T4 monotherapy

2017 study of T2 hormones, blood glucose and other metabolic markers

Do you know about the effects of the two kinds of T2 thyroid hormone that your body produces? A significant 2017 mouse study examined treatment with T3 as well as two types of T2 hormone. One type of T2 is produced from T3, and the other is produced from Reverse T3. Guess what? The product …

Continue reading 2017 study of T2 hormones, blood glucose and other metabolic markers

2018 study on T4 and T3 in breast cancer

Published August 2018, a new study of T4 and T3 hormones and obesity in relation to breast cancer risk found that higher levels of T4 hormone conferred greater risk, while higher T3 levels had a protective effect. The article Ortega-Olvera, C., Ulloa-Aguirre, A., Ángeles-Llerenas, A., Mainero-Ratchelous, F. E., González-Acevedo, C. E., Hernández-Blanco, M. de L., …

Continue reading 2018 study on T4 and T3 in breast cancer

HISTORY: Rosalind Pitt-Rivers, the co-discoverer of T3 hormone

The co-discoverers of the T3 hormone (triiodothyronine) in 1952 were Rosalind Pitt-Rivers, MD, PhD (London) and Dr. Jack Gross, MD, PhD (McGill) from Canada.   Rosalind Pitt-Rivers' early life Dr. Jamshed Tata, one of Pitt-Rivers' many co-authors, wrote the Biographical Memoirs of Dr. Pitt-Rivers, in 1994. This work is the main source of this profile. Tata …

Continue reading HISTORY: Rosalind Pitt-Rivers, the co-discoverer of T3 hormone